1. Home
  2. SPRY vs HTH Comparison

SPRY vs HTH Comparison

Compare SPRY & HTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRY
  • HTH
  • Stock Information
  • Founded
  • SPRY 2015
  • HTH 1998
  • Country
  • SPRY United States
  • HTH United States
  • Employees
  • SPRY N/A
  • HTH N/A
  • Industry
  • SPRY Biotechnology: Pharmaceutical Preparations
  • HTH Major Banks
  • Sector
  • SPRY Health Care
  • HTH Finance
  • Exchange
  • SPRY Nasdaq
  • HTH Nasdaq
  • Market Cap
  • SPRY 1.8B
  • HTH 2.1B
  • IPO Year
  • SPRY N/A
  • HTH 2004
  • Fundamental
  • Price
  • SPRY $11.62
  • HTH $35.10
  • Analyst Decision
  • SPRY Strong Buy
  • HTH Hold
  • Analyst Count
  • SPRY 4
  • HTH 1
  • Target Price
  • SPRY $28.75
  • HTH $32.00
  • AVG Volume (30 Days)
  • SPRY 2.3M
  • HTH 497.9K
  • Earning Date
  • SPRY 08-13-2025
  • HTH 10-23-2025
  • Dividend Yield
  • SPRY N/A
  • HTH 2.05%
  • EPS Growth
  • SPRY N/A
  • HTH 27.10
  • EPS
  • SPRY N/A
  • HTH 2.22
  • Revenue
  • SPRY $112,339,000.00
  • HTH $1,233,449,000.00
  • Revenue This Year
  • SPRY N/A
  • HTH N/A
  • Revenue Next Year
  • SPRY $182.40
  • HTH $1.15
  • P/E Ratio
  • SPRY N/A
  • HTH $15.81
  • Revenue Growth
  • SPRY 22367.80
  • HTH 4.92
  • 52 Week Low
  • SPRY $10.00
  • HTH $26.67
  • 52 Week High
  • SPRY $18.90
  • HTH $35.63
  • Technical
  • Relative Strength Index (RSI)
  • SPRY 25.12
  • HTH 75.51
  • Support Level
  • SPRY $13.32
  • HTH $35.03
  • Resistance Level
  • SPRY $14.00
  • HTH $35.58
  • Average True Range (ATR)
  • SPRY 1.00
  • HTH 0.68
  • MACD
  • SPRY -0.30
  • HTH 0.29
  • Stochastic Oscillator
  • SPRY 9.88
  • HTH 89.44

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

About HTH Hilltop Holdings Inc.

Hilltop Holdings Inc is a Dallas-based financial holding company. The Company has two primary business units, PCC (banking and mortgage origination) and Securities Holdings (broker-dealer). The banking segment includes the operations of the Bank. The banking segment provides business and consumer banking services from offices located throughout Texas and generates revenue from its portfolio of earning assets. The broker-dealer segment includes the operations of Securities Holdings, which operates through its wholly owned subsidiaries Hilltop Securities, Asset Managment LLC, etc. The broker-dealer segment generates a majority of its revenues from fees and commissions earned from investment advisory and securities brokerage services. Majority of revenue is from Banking Segment.

Share on Social Networks: